Pharma firms spend millions lobbying as Mass. lawmakers consider price controls

Pharmaceutical companies are spending millions on lobbying as lawmakers consider a bundle of bills that address rising prescription drug costs and transparency.

“Drugs are a huge contributor to health care costs, and it’s becoming, as many other parts of health care, more and more of a crisis in terms of people’s ability to pay for their health care,” state Sen. Cindy Friedman told the Herald. “We need to start with much more transparency around drug pricing, the true cost of bringing drugs to market and how those true costs relate to the cost of our drugs.”

Read more

Leave a Reply

Your email address will not be published.